Clinical trial
Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants…
NCT00440804 · Farmacon, Industry · Completed
Key facts
| NCT number | NCT00440804 |
|---|---|
| Title | Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA |
| Official title | Randomized, Double-Blind Study of Ibuprofen L-Lysine Intravenous Solution in Premature Infants for the Early Treatment of Patent Ductus Arteriosus |
| Lead sponsor | Farmacon, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Patent Ductus Arteriosus |
| Intervention type | Drug |
| Interventions | ibuprofen l-lysine iv solution (NeoProfen (R) ) |
| Start date | Dec 1, 2002 |
| Completion | Aug 1, 2005 |
| First posted | Feb 27, 2007 |
| Last update posted | Feb 27, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: